Chemours Reports Q3 2025 Financial Results with Decline in Net Sales but Net Income Recovery

The Chemours Company reported its financial results for the third quarter and first nine months of 2025, revealing a slight decline in net sales and a significant net income rebound compared to the previous year. For the three months ended September 30, 2025, Chemours generated net sales of $1.495 billion, a decrease of 1% from $1.508 billion in the same period of 2024. However, net income attributable to Chemours was $60 million, a recovery from a net loss of $32 million in the prior year. For the nine months ended September 30, 2025, net sales increased by 1% to $4.478 billion, compared to $4.423 billion in 2024, while net income showed a substantial decline to a loss of $325 million from a profit of $81 million in the same period last year.

The company's cost of goods sold rose to $1.262 billion for the third quarter, up from $1.222 billion a year earlier, primarily due to increased raw material costs. Selling, general, and administrative expenses decreased by 20% to $109 million, attributed to lower legacy legal costs. Research and development expenses remained stable, while restructuring and asset-related charges decreased significantly to $4 million from $45 million in the previous year, reflecting the company's ongoing efforts to streamline operations. The company also recorded a goodwill impairment charge of $56 million in the third quarter of 2024, which was not repeated in 2025.

Chemours continues to focus on strategic initiatives, including a recent agreement with SRF Limited to enhance its supply chain capabilities in fluoropolymers and fluoroelastomers. The company also amended its credit agreement to extend the maturity of its senior secured term loan to October 15, 2032, providing additional financial flexibility. Furthermore, Chemours entered into a receivables purchase agreement with BNP Paribas to enhance liquidity, allowing for the sale of eligible receivables up to €180 million.

Operationally, Chemours reported a 3% decrease in sales volume for the third quarter, primarily affecting its Titanium Technologies and Advanced Performance Materials segments. The company noted that the decline in volume was partially offset by a 1% increase in pricing and favorable currency movements. The Titanium Technologies segment experienced a 9% drop in net sales, while the Advanced Performance Materials segment saw a 12% decrease. The Thermal & Specialized Solutions segment, however, reported a 20% increase in net sales, driven by higher demand for its Opteon refrigerants.

Looking ahead, Chemours anticipates continued challenges in the market, particularly in the Titanium Technologies segment, due to ongoing operational disruptions and regulatory changes. The company remains committed to its sustainability goals, including a 60% reduction in greenhouse gas emissions by 2030, and is actively engaging with regulatory bodies regarding environmental compliance and remediation efforts. The company believes it has sufficient liquidity to meet its obligations through at least the end of November 2026, despite potential impacts from ongoing legal and environmental matters.